Gengraf and Catapres drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Gengraf and Catapres together.
The phase IV clinical study analyzes what interactions people who take Gengraf and Catapres have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Gengraf and Catapres together, and have interactions are studied.
What is Gengraf?
Gengraf has active ingredients of cyclosporine. eHealthMe is studying from 891 Gengraf users for its effectiveness, alternative drugs and more.
What is Catapres?
Catapres has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,374 Catapres users for its effectiveness, alternative drugs and more.
Number of Gengraf and Catapres reports submitted per year:
Common Gengraf and Catapres drug interactions by gender *:
female:
n/a
male:
- Anaemia
- Essential hypertension
- Atrophy
- Back pain
- Balance disorder
- Confusional state
- Diabetes mellitus
- Diabetic neuropathy
- Dizziness
- Dysarthria
Common Gengraf and Catapres drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Areflexia
- Arthralgia
- Dysarthria
- Dyskinesia
- Emotional disorder
- Extrapyramidal disorder
- Gait disturbance
- Hypoaesthesia
- Injury
- Muscle atrophy
60+:
n/a
* Approximation only. Some reports may have incomplete information.
Do you take Gengraf and Catapres?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Gengraf and Catapres:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Catapres side effects:
- High blood pressure: 699 reports
- Pain: 604 reports
- Fatigue (feeling of tiredness): 516 reports
- Headache (pain in head): 468 reports
- Weakness: 436 reports
- Rashes (redness): 357 reports
- Stress and anxiety: 347 reports
Browse all side effects of Catapres:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Gengraf interactions:
- Gengraf and Prednisone: 255 reports
- Gengraf and Cellcept: 154 reports
- Gengraf and Aspirin: 123 reports
Browse all interactions between Gengraf and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Catapres interactions:
- Catapres and Lasix: 999 reports
- Catapres and Norvasc: 973 reports
- Catapres and Aspirin: 907 reports
- Catapres and Lipitor: 572 reports
- Catapres and Lisinopril: 534 reports
- Catapres and Tylenol: 526 reports
- Catapres and Prilosec: 512 reports
- Catapres and Synthroid: 490 reports
- Catapres and Clonidine: 471 reports
- Catapres and Protonix: 467 reports
Browse all interactions between Catapres and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cyclosporine and clonidine hydrochloride (the active ingredients of Gengraf and Catapres, respectively), and Gengraf and Catapres (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Gengraf and Catapres.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zoloft and Polycythemia Vera - 7 seconds ago
- Vitamins and Ventricular Failure - 12 seconds ago
- Ibandronate Sodium and Blood Urine Present - 15 seconds ago
- Bydureon Bcise and Insomnia - 16 seconds ago
- Topicort and Rosuvastatin Calcium drug interaction - 20 seconds ago
- Pentazocine and Body Temperature Increased - 20 seconds ago
- Dymista and Bumex drug interaction - 22 seconds ago
- Tikosyn and Nightmares - 25 seconds ago
- Tretinoin and Quality Of Life Decreased - 27 seconds ago
- Albuterol and Dementia - 29 seconds ago